Annual Operating Expenses
$7.27 M
-$1.46 M-16.69%
31 December 2023
Summary:
ZIVO Bioscience annual total operating expenses is currently $7.27 million, with the most recent change of -$1.46 million (-16.69%) on 31 December 2023. During the last 3 years, it has fallen by -$1.30 million (-15.17%). ZIVO annual operating expenses is now -16.69% below its all-time high of $8.73 million, reached on 31 December 2022.ZIVO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$2.27 M
-$5.96 M-72.42%
30 September 2024
Summary:
ZIVO Bioscience quarterly total operating expenses is currently $2.27 million, with the most recent change of -$5.96 million (-72.42%) on 30 September 2024. Over the past year, it has increased by +$693.00 thousand (+43.96%). ZIVO quarterly operating expenses is now -72.42% below its all-time high of $8.23 million, reached on 30 June 2024.ZIVO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.7% | +44.0% |
| 3 y3 years | -15.2% | +35.6% |
| 5 y5 years | +18.7% | +44.2% |
ZIVO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.7% | at low | -72.4% | +76.2% |
| 5 y | 5 years | -16.7% | +18.7% | -72.4% | +120.4% |
| alltime | all time | -16.7% | >+9999.0% | -72.4% | >+9999.0% |
ZIVO Bioscience Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.27 M(-72.4%) |
| June 2024 | - | $8.23 M(+538.8%) |
| Mar 2024 | - | $1.29 M(-32.2%) |
| Dec 2023 | $7.27 M(-16.7%) | $1.90 M(+20.6%) |
| Sept 2023 | - | $1.58 M(-13.7%) |
| June 2023 | - | $1.83 M(-7.3%) |
| Mar 2023 | - | $1.97 M(-25.3%) |
| Dec 2022 | $8.73 M(+1.0%) | $2.64 M(+31.9%) |
| Sept 2022 | - | $2.00 M(-3.3%) |
| June 2022 | - | $2.07 M(+2.0%) |
| Mar 2022 | - | $2.03 M(-37.9%) |
| Dec 2021 | $8.65 M(+0.8%) | $3.26 M(+95.1%) |
| Sept 2021 | - | $1.67 M(-4.4%) |
| June 2021 | - | $1.75 M(-16.0%) |
| Mar 2021 | - | $2.08 M(+18.7%) |
| Dec 2020 | $8.58 M(+2.7%) | $1.75 M(-47.8%) |
| Sept 2020 | - | $3.36 M(+226.7%) |
| June 2020 | - | $1.03 M(-57.5%) |
| Mar 2020 | - | $2.43 M(-35.7%) |
| Dec 2019 | $8.35 M(+36.2%) | $3.77 M(+139.7%) |
| Sept 2019 | - | $1.57 M(-22.7%) |
| June 2019 | - | $2.04 M(+110.5%) |
| Mar 2019 | - | $967.90 K(-40.2%) |
| Dec 2018 | $6.13 M(-3.2%) | $1.62 M(+8.2%) |
| Sept 2018 | - | $1.49 M(+12.0%) |
| June 2018 | - | $1.34 M(-20.7%) |
| Mar 2018 | - | $1.68 M(-35.2%) |
| Dec 2017 | $6.33 M(+81.4%) | $2.60 M(+26.0%) |
| Sept 2017 | - | $2.06 M(+133.8%) |
| June 2017 | - | $881.40 K(+11.4%) |
| Mar 2017 | - | $791.30 K(+23.1%) |
| Dec 2016 | $3.49 M(+14.2%) | $642.70 K(-5.1%) |
| Sept 2016 | - | $677.10 K(-55.7%) |
| June 2016 | - | $1.53 M(+138.9%) |
| Mar 2016 | - | $640.60 K(-3.5%) |
| Dec 2015 | $3.06 M(-18.8%) | $663.70 K(-15.8%) |
| Sept 2015 | - | $788.30 K(-24.3%) |
| June 2015 | - | $1.04 M(+85.2%) |
| Mar 2015 | - | $562.40 K(-48.2%) |
| Dec 2014 | $3.76 M(+21.0%) | $1.09 M(-1.0%) |
| Sept 2014 | - | $1.10 M(+36.9%) |
| June 2014 | - | $800.70 K(+2.8%) |
| Mar 2014 | - | $778.80 K(-3.2%) |
| Dec 2013 | $3.11 M(+49.5%) | $804.30 K(-9.4%) |
| Sept 2013 | - | $888.10 K(+0.6%) |
| June 2013 | - | $882.40 K(+64.8%) |
| Mar 2013 | - | $535.30 K(+22.1%) |
| Dec 2012 | $2.08 M | $438.30 K(-32.9%) |
| Sept 2012 | - | $653.30 K(+35.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $481.80 K(-5.0%) |
| Mar 2012 | - | $507.20 K(-45.3%) |
| Dec 2011 | $1.90 M(-53.5%) | $926.70 K(+214.1%) |
| Sept 2011 | - | $295.00 K(+14.6%) |
| June 2011 | - | $257.50 K(-39.4%) |
| Mar 2011 | - | $424.70 K(-42.7%) |
| Dec 2010 | $4.09 M(+53.3%) | $741.60 K(+33.2%) |
| Sept 2010 | - | $556.70 K(-69.4%) |
| June 2010 | - | $1.82 M(+87.0%) |
| Mar 2010 | - | $973.40 K(+23.2%) |
| Dec 2009 | $2.67 M(+112.3%) | $790.20 K(-21.7%) |
| Sept 2009 | - | $1.01 M(+201.9%) |
| June 2009 | - | $334.10 K(-37.6%) |
| Mar 2009 | - | $535.80 K(+135.5%) |
| Dec 2008 | $1.26 M(-43.6%) | $227.50 K(-17.5%) |
| Sept 2008 | - | $275.80 K(-41.3%) |
| June 2008 | - | $470.10 K(+65.8%) |
| Mar 2008 | - | $283.50 K(-27.6%) |
| Dec 2007 | $2.23 M(-42.6%) | $391.40 K(-44.8%) |
| Sept 2007 | - | $708.80 K(+50.6%) |
| June 2007 | - | $470.80 K(-28.4%) |
| Mar 2007 | - | $657.10 K(-38.7%) |
| Dec 2006 | $3.88 M(+25.9%) | $1.07 M(+69.3%) |
| Sept 2006 | - | $633.00 K(-47.5%) |
| June 2006 | - | $1.21 M(+24.1%) |
| Mar 2006 | - | $972.30 K(+6.4%) |
| Dec 2005 | $3.08 M(-19.5%) | $913.50 K(-42.9%) |
| Sept 2005 | - | $1.60 M(+400.9%) |
| June 2005 | - | $319.30 K(-5.1%) |
| Mar 2005 | - | $336.60 K(-39.4%) |
| Dec 2004 | $3.83 M(+608.7%) | $555.80 K(-41.2%) |
| Sept 2004 | - | $945.30 K(+31.0%) |
| June 2004 | - | $721.40 K(-55.2%) |
| Mar 2004 | - | $1.61 M(+199.8%) |
| Dec 2003 | $540.60 K(>+9900.0%) | $537.60 K(>+9900.0%) |
| Sept 2003 | - | $600.00(0.0%) |
| June 2003 | - | $600.00(-68.4%) |
| Mar 2003 | - | $1900.00(+216.7%) |
| Dec 2002 | $3400.00(+61.9%) | $600.00(0.0%) |
| Sept 2002 | - | $600.00(0.0%) |
| June 2002 | - | $600.00(-62.5%) |
| Mar 2002 | - | $1600.00(+166.7%) |
| Dec 2001 | $2100.00(-41.7%) | $600.00(0.0%) |
| Sept 2001 | - | $600.00(0.0%) |
| June 2001 | - | $600.00(+200.0%) |
| Mar 2001 | - | $200.00(-93.3%) |
| Dec 2000 | $3600.00 | $3000.00(+400.0%) |
| Sept 2000 | - | $600.00(-96.1%) |
| Sept 1999 | - | $15.20 K |
FAQ
- What is ZIVO Bioscience annual total operating expenses?
- What is the all time high annual operating expenses for ZIVO Bioscience?
- What is ZIVO Bioscience annual operating expenses year-on-year change?
- What is ZIVO Bioscience quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly operating expenses year-on-year change?
What is ZIVO Bioscience annual total operating expenses?
The current annual operating expenses of ZIVO is $7.27 M
What is the all time high annual operating expenses for ZIVO Bioscience?
ZIVO Bioscience all-time high annual total operating expenses is $8.73 M
What is ZIVO Bioscience annual operating expenses year-on-year change?
Over the past year, ZIVO annual total operating expenses has changed by -$1.46 M (-16.69%)
What is ZIVO Bioscience quarterly total operating expenses?
The current quarterly operating expenses of ZIVO is $2.27 M
What is the all time high quarterly operating expenses for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly total operating expenses is $8.23 M
What is ZIVO Bioscience quarterly operating expenses year-on-year change?
Over the past year, ZIVO quarterly total operating expenses has changed by +$693.00 K (+43.96%)